RR
INSIDER · ANTX · AN2 Therapeutics, Inc. · DIRECTOR
Readnour Robin Shane
Every open-market transaction filed under this name, Sep 3 to Sep 9.
Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$104K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 9 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 585 | $6.02 | $4K | — |
| Sep 9 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 523 | $6.02 | $3K | — |
| Sep 8 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 5,294 | $6.02 | $32K | — |
| Sep 8 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 4,725 | $6.02 | $28K | — |
| Sep 3 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 3,223 | $6.07 | $20K | — |
| Sep 3 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 2,877 | $6.07 | $17K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.